{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:19:56Z","timestamp":1776399596023,"version":"3.51.2"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer J"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>More than half of all patients with non\u2013small cell lung cancer (NSCLC) have metastatic disease at the time of diagnosis. A subset of these patients has oligometastatic disease, which exists in an intermediary state between locoregional and disseminated metastatic disease. In addition, some metastatic patients on systemic therapy may have limited disease progression, or oligoprogression. Historically, treatment of metastatic NSCLC was palliative in nature, with little expectation of long-term survival. However, an accumulation of evidence over the past 3 decades now demonstrates that local ablative therapy to sites of limited metastases or progression can improve patient outcomes for this complex disease. This review examines the evidence behind local ablative therapy in oligometastatic and oligoprogressive NSCLC, with a focus on surgery, stereotactic radiotherapy, and radiofrequency ablation.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000433","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T04:20:14Z","timestamp":1585023614000},"page":"129-136","source":"Crossref","is-referenced-by-count":12,"title":["Local Ablative Therapies for Oligometastatic and Oligoprogressive Non\u2013Small Cell Lung Cancer"],"prefix":"10.1097","volume":"26","author":[{"given":"Vikram","family":"Jairam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy H.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230924","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.lungcan.2013.08.006","article-title":"Local treatment of oligometastatic recurrence in patients with resected non\u2013small cell lung cancer","volume":"82","year":"2013","journal-title":"Lung Cancer"},{"key":"bib2-20230924","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.cllc.2016.06.011","article-title":"Patterns of distant metastases after surgical management of non\u2013small-cell lung cancer","volume":"18","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"bib3-20230924","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","article-title":"Oligometastases","volume":"13","year":"1995","journal-title":"J Clin Oncol"},{"key":"bib4-20230924","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","article-title":"Oligometastases revisited","volume":"8","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"bib5-20230924","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"bib6-20230924","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","article-title":"Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study","volume":"17","year":"2016","journal-title":"Lancet Oncol"},{"key":"bib7-20230924","doi-asserted-by":"crossref","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non\u2013small-cell lung cancer: a phase 2 randomized clinical trial","volume":"4","year":"2018","journal-title":"JAMA Oncol"},{"key":"bib8-20230924","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3171\/jns.1995.83.4.0605","article-title":"Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991","volume":"83","year":"1995","journal-title":"J Neurosurg"},{"key":"bib9-20230924","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0003-4975(00)02509-1","article-title":"Resection of adrenal metastases from non\u2013small cell lung cancer: a multicenter study","volume":"71","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"bib10-20230924","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21818","article-title":"Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis","volume":"106","year":"2006","journal-title":"Cancer"},{"key":"bib11-20230924","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ijrobp.2014.04.007","article-title":"Definitive primary therapy in patients presenting with oligometastatic non\u2013small cell lung cancer","volume":"89","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib12-20230924","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S1470-2045(08)70155-4","article-title":"Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)","volume":"9","year":"2008","journal-title":"Lancet Oncol"},{"key":"bib13-20230924","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2013.11.010","article-title":"Stereotactic radiation therapy can safely and durably control sites of extra\u2013central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib","volume":"88","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib14-20230924","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study","volume":"37","year":"2019","journal-title":"J Clin Oncol"},{"key":"bib15-20230924","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1001\/jamaoncol.2019.1449","article-title":"Pembrolizumab after completion of locally ablative therapy for oligometastatic non\u2013small cell lung cancer: a phase 2 trial","volume":"5","year":"2019","journal-title":"JAMA Oncol"},{"key":"bib16-20230924","doi-asserted-by":"crossref","first-page":"455","DOI":"10.21037\/tlcr.2016.10.07","article-title":"Liquid biopsy based biomarkers in non\u2013small cell lung cancer for diagnosis and treatment monitoring","volume":"5","year":"2016","journal-title":"Transl Lung Cancer Res"},{"key":"bib17-20230924","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5223(97)70397-0","article-title":"Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases","volume":"113","year":"1997","journal-title":"J Thorac Cardiovasc Surg"},{"key":"bib18-20230924","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2004.12.149","article-title":"Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit Cancer Surveillance System","volume":"22","year":"2004","journal-title":"J Clin Oncol"},{"key":"bib19-20230924","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cncr.10541","article-title":"Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma","volume":"94","year":"2002","journal-title":"Cancer"},{"key":"bib20-20230924","first-page":"483","article-title":"Primary carcinoma of the lungs. IV intracranial metastases","volume":"9","year":"1930","journal-title":"Arch Pathol"},{"key":"bib21-20230924","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0003-4975(10)60536-X","article-title":"Surgical approach to lung cancer with solitary cerebral metastasis: twenty-five years' experience","volume":"42","year":"1986","journal-title":"Ann Thorac Surg"},{"key":"bib22-20230924","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-5223(19)34267-9","article-title":"Management of nonsmall cell lung carcinoma with solitary brain metastasis","volume":"98","year":"1989","journal-title":"J Thorac Cardiovasc Surg"},{"key":"bib23-20230924","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/1097-0142(19910715)68:2<300::AID-CNCR2820680215>3.0.CO;2-S","article-title":"Results and prognostic factors of surgery in the management of non\u2013small cell lung cancer with solitary brain metastasis","volume":"68","year":"1991","journal-title":"Cancer"},{"key":"bib24-20230924","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1378\/chest.119.5.1469","article-title":"Surgical management of non\u2013small cell lung cancer with synchronous brain metastases","volume":"119","year":"2001","journal-title":"Chest"},{"key":"bib25-20230924","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1010-7940(01)00744-8","article-title":"Non\u2013small cell lung cancer with single brain metastasis: the role of surgical treatment","volume":"20","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"bib26-20230924","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mtc.2001.116201","article-title":"Surgical treatment of primary lung cancer with synchronous brain metastases","volume":"122","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"bib27-20230924","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/02841869709001267","article-title":"Metastatic pattern at autopsy in non-resectable adenocarcinoma of the lung\u2014a study from a cohort of 259 consecutive patients treated with chemotherapy","volume":"36","year":"1997","journal-title":"Acta Oncol"},{"key":"bib28-20230924","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.athoracsur.2011.05.116","article-title":"Outcomes of patients with isolated adrenal metastasis from non\u2013small cell lung carcinoma","volume":"92","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"bib29-20230924","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ejcts.2005.01.047","article-title":"Metachronous adrenal masses in resected non\u2013small cell lung cancer patients: therapeutic implications of laparoscopic adrenalectomy","volume":"27","year":"2005","journal-title":"Eur J Cardiothorac Surg"},{"key":"bib30-20230924","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/jama.1982.03330050063034","article-title":"Successful treatment of adrenal metastases from large-cell carcinoma of the lung","volume":"248","year":"1982","journal-title":"JAMA"},{"key":"bib31-20230924","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/(SICI)1096-9098(199809)69:1<54::AID-JSO11>3.0.CO;2-N","article-title":"Surgical management of adrenal metastases from lung cancer","volume":"69","year":"1998","journal-title":"J Surg Oncol"},{"key":"bib32-20230924","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jtcvs.2004.09.020","article-title":"Surgical treatment of solitary adrenal metastasis from non\u2013small cell lung cancer","volume":"130","year":"2005","journal-title":"J Thorac Cardiovasc Surg"},{"key":"bib33-20230924","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.lungcan.2005.02.012","article-title":"Adrenalectomy for solitary adrenal metastases from non\u2013small cell lung cancer","volume":"49","year":"2005","journal-title":"Lung Cancer"},{"key":"bib34-20230924","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1200\/JCO.2007.14.2091","article-title":"Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non\u2013small-cell lung cancer: a systematic review and pooled analysis","volume":"26","year":"2008","journal-title":"J Clin Oncol"},{"key":"bib35-20230924","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0003-4975(96)00611-X","article-title":"Does resection of adrenal metastases from non\u2013small cell lung cancer improve survival?","volume":"62","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"bib36-20230924","first-page":"124","article-title":"Surgical treatment of adrenal metastasis following pulmonary resection for lung cancer: comparison of adrenalectomy with palliative therapy","volume":"79","year":"1994","journal-title":"Int Surg"},{"key":"bib37-20230924","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","article-title":"Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial","volume":"295","year":"2006","journal-title":"JAMA"},{"key":"bib38-20230924","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","year":"2009","journal-title":"Lancet Oncol"},{"key":"bib39-20230924","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","article-title":"Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study","volume":"29","year":"2011","journal-title":"J Clin Oncol"},{"key":"bib40-20230924","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2019.03.052","article-title":"Initial SRS for patients with 5 to 15 brain metastases: results of a multi-institutional experience","volume":"104","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib41-20230924","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","year":"2014","journal-title":"Lancet Oncol"},{"key":"bib42-20230924","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2217\/cns.13.4","article-title":"Role of stereotactic radiosurgery in patients with more than four brain metastases","volume":"2","year":"2013","journal-title":"CNS Oncol"},{"key":"bib43-20230924","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","year":"2010","journal-title":"JAMA"},{"key":"bib44-20230924","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.soc.2013.02.011","article-title":"Stereotactic body radiation therapy for treatment of primary and metastatic pulmonary malignancies","volume":"22","year":"2013","journal-title":"Surg Oncol Clin N Am"},{"key":"bib45-20230924","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for lung metastases","volume":"27","year":"2009","journal-title":"J Clin Oncol"},{"key":"bib46-20230924","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","year":"2009","journal-title":"J Clin Oncol"},{"key":"bib47-20230924","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1470-2045(11)70384-9","article-title":"Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1\u20132 trial","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"key":"bib48-20230924","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaoncol.2019.0192","article-title":"Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial","volume":"5","year":"2019","journal-title":"JAMA Oncol"},{"key":"bib49-20230924","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1067\/mtc.2002.121678","article-title":"Stage III non\u2013small cell lung cancer and metachronous brain metastases","volume":"124","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"bib50-20230924","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijrobp.2007.12.031","article-title":"Long-term survival in patients with synchronous, solitary brain metastasis from non\u2013small-cell lung cancer treated with radiosurgery","volume":"72","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib51-20230924","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.ijrobp.2012.02.054","article-title":"Prognostic impact of radiation therapy to the primary tumor in patients with non\u2013small cell lung cancer and oligometastasis at diagnosis","volume":"84","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"bib52-20230924","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3389\/fonc.2018.00395","article-title":"Diagnosis and management of radiation necrosis in patients with brain metastases","volume":"8","year":"2018","journal-title":"Front Oncol"},{"key":"bib53-20230924","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-6-48","article-title":"Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis","volume":"6","year":"2011","journal-title":"Radiat Oncol"},{"key":"bib54-20230924","first-page":"5","article-title":"Lung radiofrequency ablation: potential as a therapy to oligometastasis and oligorecurrence","volume":"2012","year":"2012","journal-title":"Pulm Med"},{"key":"bib55-20230924","first-page":"e460","article-title":"Local therapy for limited metastatic non\u2013small cell lung cancer: what are the options and is there a benefit?","volume":"35","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"bib57-20230924","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1148\/radiol.2431060088","article-title":"Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients","volume":"243","year":"2007","journal-title":"Radiology"},{"key":"bib58-20230924","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00270-011-0220-0","article-title":"Lung radiofrequency ablation for the treatment of unresectable recurrent non\u2013small-cell lung cancer after surgical intervention","volume":"35","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"bib59-20230924","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00270-011-0194-y","article-title":"Comparison of survival rate in primary non\u2013small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy","volume":"35","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"bib60-20230924","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/cncr.29507","article-title":"Radiofrequency ablation of stage IA non\u2013small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial","volume":"121","year":"2015","journal-title":"Cancer"},{"key":"bib61-20230924","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1148\/radiol.2411051087","article-title":"Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors","volume":"241","year":"2006","journal-title":"Radiology"},{"key":"bib62-20230924","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.hpb.2018.10.019","article-title":"Demographic and facility volume related outcomes in radiofrequency ablation for early-stage hepatocellular carcinoma","volume":"21","year":"2019","journal-title":"HPB (Oxford)"},{"key":"bib63-20230924","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.lungcan.2013.07.026","article-title":"Is there an oligometastatic state in non\u2013small cell lung cancer? A systematic review of the literature","volume":"82","year":"2013","journal-title":"Lung Cancer"},{"key":"bib64-20230924","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cllc.2014.04.003","article-title":"An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non\u2013small-cell lung cancer","volume":"15","year":"2014","journal-title":"Clin Lung Cancer"},{"key":"bib65-20230924","doi-asserted-by":"crossref","first-page":"20160251","DOI":"10.1259\/bjr.20160251","article-title":"Stereotactic body radiotherapy for oligoprogressive cancer","volume":"89","year":"2016","journal-title":"Br J Radiol"},{"key":"bib66-20230924","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"key":"bib67-20230924","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1158\/0008-5472.CAN-15-0377","article-title":"Intratumoral heterogeneity in EGFR-mutant NSCLC results in divergent resistance mechanisms in response to EGFR tyrosine kinase inhibition","volume":"75","year":"2015","journal-title":"Cancer Res"},{"key":"bib68-20230924","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/JTO.0b013e31827e1f83","article-title":"Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors","volume":"8","year":"2013","journal-title":"J Thorac Oncol"},{"key":"bib69-20230924","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/JTO.0b013e3182745948","article-title":"Local ablative therapy of oligoprogressive disease prolongs disease control by tyrosine kinase inhibitors in oncogene-addicted non\u2013small-cell lung cancer","volume":"7","year":"2012","journal-title":"J Thorac Oncol"},{"key":"bib70-20230924","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.lungcan.2011.04.007","article-title":"Continuous EGFR-TKI administration following radiotherapy for non\u2013small cell lung cancer patients with isolated CNS failure","volume":"74","year":"2011","journal-title":"Lung Cancer"},{"key":"bib72-20230924","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3747\/co.26.4116","article-title":"Canadian consensus: oligoprogressive, pseudoprogressive, and oligometastatic non\u2013small-cell lung cancer","volume":"26","year":"2019","journal-title":"Curr Oncol"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T05:17:36Z","timestamp":1695532656000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000433","relation":{},"ISSN":["1540-336X","1528-9117"],"issn-type":[{"value":"1540-336X","type":"electronic"},{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}